The European Commission has approved two new delivery formats for Nucala (mepolizumab) – a pre-filled pen injector and a pre-filled safety syringe – that will allow patients with eosinophilic ...

GSK has been studying Nucala in COPD for some time, and in 2017 reported mixed results for the drug in two earlier phase 3 trials called METREX and METREO. METREX involved patients with a range of ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal ...

GSK announced that its monoclonal antibody, Nucala (mepolizumab), has been approved ... indication for mepolizumab in China and offers patients a non-surgical treatment alternative to systemic ...

GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal ... for the treatment of adult patients with chronic rhinosinusitis with nasal polyps ...

Nucala was approved as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with CRSwNP for whom therapy with systemic corticosteroids and/or surgery do not ...

GSK Plc was up as the China National Medical Products Administration approved the drugmaker’s Nucala (mepolizumab) as an add-on therapy for the treatment of adult patients with chronic rhinosinusitis.

Patients should stop treatment if hepatic injury ... UPDATED: Friday, Jan. 3 at 2:45 p.m. ET GSK’s IL-5 inhibitor Nucala scored a nod in China to treat people with inadequately controlled ...

Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients.

GSK’s Nucala was approved in the US for severe asthma with an eosinophilic phenotype treatment. Credit: MAXSHOT.PL / Shutterstock. The China National Medical Products Administration (NMPA) has ...